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The cellular protein cyclophilin A (CypA) is packaged into human immunodeficiency virus type 1 (HIV-1) virions through a
specific interaction with the capsid (CA) domain of the Gag polyprotein. CypA is important for infectivity, but its role in viral
replication is currently unknown. Previous reports suggested that CypA promotes uncoating or enhances maturation. We
analyzed the morphology and capsid stability of HIV-1 variants defective in CypA binding and of virus grown in the presence
of cyclosporin. Both cyclosporin treatment and alteration of Gly89 or Pro90 in the CypA-binding site of CA caused a 5- to
20-fold decrease in CypA incorporation. Virus produced from cyclosporin-treated cells and variants G89V and G89A were 10-
to 100-fold less infectious but exhibited normal virion morphologies with regular cone-shaped capsids. Irregular capsid
morphologies and lower infectivities were observed for some other variants in the CypA-binding region. Decreased CypA
incorporation did not reduce the kinetics of intracellular polyprotein processing or of virus release. No increase in immature
particles was observed. These results suggest that CypA does not promote virion maturation. Furthermore, detergent
stripping of virus particles with various CypA contents revealed no difference in capsid stability. Based on these results and
those reported in the accompanying paper, it appears likely that CypA also is not an uncoating factor. Alternative models for
CypA function are discussed. © 1999 Academic Press
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The retroviral Gag polyprotein and its proteolytic cleav-
ge products are the major structural components of the
irion. Gag alone is sufficient to direct the assembly and
elease of virus-like particles in the absence of any other
iral protein (Craven et al., 1996; Gheysen et al., 1989;
hields et al., 1978; Wills and Craven, 1991). In the case
f human immunodeficiency virus (HIV), the accumula-
ion of Gag polyproteins at the plasma membrane leads
o assembly of immature virions that bud from the cell
urface. These noninfectious particles contain a spheri-
al protein shell closely apposed to the lipid membrane
Fuller et al., 1997; Gelderblom, 1991; O¨hagen et al.,
997). Within the nascent virion, the Pr55gag polyprotein of
IV type 1 (HIV-1) is cleaved by the viral proteinase (PR)
nto the matrix (MA), capsid (CA), and nucleocapsid (NC)
roteins and several smaller peptides (reviewed in
ra¨usslich and Wimmer, 1988; Kuo and Shafer, 1994; for
omenclature, see Leis et al., 1988). These cleavages
ead to a dramatic reorganization of the internal virion
tructure termed maturation, which is essential for infec-
ivity (Kohl et al., 1988). In mature HIV-1 particles, MA
ines the inner surface of the membrane, whereas CA
orms the cone-shaped capsid shell that encases a ribo-
1 To whom reprint requests should be addressed at Martinistr. 52.
Bax: 49-40-48051-184. E-mail: hgk@hpi.uni-hamburg.de.
261ucleoprotein complex consisting of the genomic RNA
ound to NC and other viral replication proteins (Gelder-
lom, 1991; Wills and Craven, 1991).
Although Gag alone is clearly sufficient to direct the
roduction of immature virions, it appeared likely that
ost factors may modulate the folding of structural
olyproteins, the assembly of virus particles, or the mat-
ration process. The search for cellular proteins as bind-
ng partners for HIV-1 Gag proteins led to the discovery
f cyclophilin A (CypA) as an integral constituent of the
IV-1 virion (Franke et al., 1994; Luban et al., 1993; Thali
t al., 1994). CypA is an abundant cytosolic form of the
yclophilin family of peptidyl-prolyl cis-trans isomerases.
pecific incorporation of CypA into HIV-1 virions is me-
iated through its binding to a proline-rich region, which
orms a solvent exposed loop in the amino-terminal part
f the CA domain of Gag (Franke et al., 1994; Gamble et
l., 1996). In the HIV-1 particle, ;1 CypA molecule is
ackaged per 10 molecules of Gag (Franke et al., 1994).
ypA also binds to the completely processed HIV-1 CA
rotein in vitro (Billich et al., 1995; Luban et al., 1993; Yoo
t al., 1997), making it likely that it remains attached to
he cone-shaped capsid after maturation. CypA binding
o Gag and CypA incorporation into virus particles are
isrupted by the pharmacological agent cyclosporin in a
ose-dependent manner, and these effects correlate
ith a reduction in viral infectivity (Braaten et al., 1996;
ukovsky et al., 1997; Franke et al., 1994; Thali et al.,
0042-6822/99 $30.00
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262 WIEGERS ET AL.994). Similar effects have been observed for viruses
ontaining alterations in the CypA-binding loop of CA,
pecifically mutations exchanging either Pro90 or Gly89
f the CA domain to alanine codons (Braaten et al., 1996).
urthermore, mutations in the CypA-binding loop can
onfer resistance to cyclosporin, providing genetic evi-
ence that HIV-1 CA is indeed the functional target of
ypA (Aberham et al., 1996). Remarkably, the Gag
olyproteins of the closely related lentiviruses HIV-2 and
imian immunodeficiency virus (SIV) do not bind to CypA;
hese viruses do not package CypA into virions and are
ot inhibited by cyclosporins (Billich et al., 1995; Franke
t al., 1994; Thali et al., 1994). However, SIV packages
ypA and becomes sensitive to a cyclosporin analog
hen either its entire CA domain or an eight-amino-acid
egment corresponding to the CypA-binding loop of
IV-1 is replaced by the analogous region from HIV-1
Bukovsky et al., 1997; Dorfman and Go¨ttlinger, 1996).
The described results do not directly address how
ypA exerts its effect and where in the HIV-1 life cycle its
resence is important. A straightforward hypothesis
ould be the assumption that CypA catalyzes the cis-
rans isomerization of a peptidyl-prolyl bond, most likely
nvolving Pro90 in the CypA-binding loop. Structural anal-
sis showed, however, that Pro90 adopted the trans
onformation even when complexed with CypA, making
t less likely that isomerization of this residue constitutes
he mechanism of CypA function. Based on these data, it
as suggested that CypA acts as a sequence-specific
A-binding protein that may exert its function by weak-
ning the association of CA multimers in the virion,
hereby promoting disassembly of the viral capsid early
n infection (Braaten et al., 1996; Gamble et al., 1996).
nalysis of chimeric SIV particles containing segments
f the HIV-1 CA domain showed that the presence of
IV-1-derived residues corresponding to the CypA-bind-
ng site was required for virion incorporation of CypA,
hereas adjacent residues not overlapping with the pri-
ary binding site determined whether CypA incorpora-
ion enhanced or inhibited viral infectivity (Bukovsky et
l., 1997). In HIV-1 CA, these residues form a type II tight
urn (Gitti et al., 1996), and CypA may modulate CA–CA
nteractions involving this turn. Support for this hypothe-
is can be drawn from in vitro selected HIV-1 variants
hat require the presence of cyclosporin for replication
ith the relevant mutations mapping to residues consti-
uting this turn (Aberham et al., 1996).
Blocking CypA incorporation into HIV-1 virions by cy-
losporin treatment or mutation of the CypA-binding site
f CA does not detectably alter the efficiency of virus
elease or the overall biochemical composition of the
irion (Braaten et al., 1996; Franke et al., 1994; Thali et al.,
994). Furthermore, virions released from cyclosporin-
reated cells have been reported to adopt a normal mor-
hology (Braaten et al., 1996), although this suggestion
as been questioned in a recent study that showed a mubtle cyclosporin-induced defect in polyprotein pro-
essing and virion maturation (Streblow et al., 1998).
IV-1 particles lacking normal quantities of CypA appear
o enter cells normally but to be blocked at an early step
fter penetration, and this block cannot be rescued by
ypA present in the target cell (Braaten et al., 1996; Thali
t al., 1994). Blockage probably occurs before reverse
ranscription (Braaten et al., 1996), although one group
as reported that cDNA is produced normally but fails to
each the nucleus (Steinkasserer et al., 1995). These
esults have been taken to suggest that CypA is func-
ioning in the early uncoating process after the newly
nfecting virion has entered the host cell, possibly by
estabilizing CA–CA protein interactions (Gamble et al.,
996).
To further analyze the effect of CypA on HIV-1 replica-
ion, we determined the phenotype of a panel of HIV-1
utants defective in CypA binding as well as of HIV-1
rown in the presence or absence of cyclosporin regard-
ng particle production, virion morphology, polyprotein
rocessing, capsid stability, and infectivity. In the accom-
anying paper (Gra¨ttinger et al., 1999), we analyzed the
henotype of the respective variant CA proteins regard-
ng CypA binding and in vitro assembly and disassembly
f particulate structures. Taken together, these results
uggest that CypA incorporation does not influence
irion maturation and does not detectably alter capsid
tability.
RESULTS
onstruction of CypA-binding mutants and analysis of
ypA incorporation and viral infectivity
Previously, it has been shown that CypA packaging
nto HIV-1 particles is important for viral infectivity. Incor-
oration is mediated by a specific interaction with amino
cids Gly89 and Pro90 in the cyclophilin loop within the
mino-terminal domain of CA (Franke et al., 1994; Gam-
le et al., 1996). To determine the role of CypA in virion
orphology, maturation, and capsid stability, several
ubstitutions were introduced in positions 89 and 90 of
he CA coding region. Mutant P90L was constructed in
he proviral clone pHXBH10, whereas all mutations of
ly89 were made in the proviral clone pNL4-3. Proviral
lasmids encoding wild-type and mutated sequences
ere transiently transfected into HeLa P4/CCR5 cells,
nd the expression and processing of HIV-1-pecific pro-
eins, as well as particle release and infectivity, were
nalyzed. Cells transfected with the wild-type plasmid
NL4-3 and grown in the presence of 5 mM cyclosporin
ere analyzed in parallel.
Western blot analysis of transfected cells using an
ntiserum against CA revealed comparable amounts of
mmunoreactive material for wild-type-transfected cells
n the presence and absence of cyclosporin and for allutants (Fig. 1A). Completely processed CA protein was
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263CYCLOPHILIN A INCORPORATION AND HIV TYPE 1he predominant product in all cases, with some Gag
olyprotein (Pr55gag) and two intermediate processing
roducts (presumably MA-CA and MA-CA-NC) remaining
Fig. 1A). More cell-associated immunoreactive material
as reproducibly observed in transfections of pHXBH10
nd the derived P90L mutant (Fig. 1A, lanes 9 and 10)
ompared with pNL4-3 and its derivatives. Virus particles
solated from the culture supernatants by centrifugation
hrough a sucrose cushion also revealed comparable
mounts of immunoreactive material, mostly correspond-
ng to completely processed CA protein (Fig. 1B). Equal
mounts of material were loaded in the respective lanes
n Figs. 1A and 1B, and the observed result indicates that
yclosporin treatment or mutation of the CypA-binding
ite had no significant effect on virus release. Processing
FIG. 1. Immunoblot analysis of HIV-1 Gag proteins and CypA. HeLa P4/CC
4 h after transfection (A–C). Lysates of transfected cells (A) or viral particle
y SDS–PAGE and Western blotting. Specific products were detected using
nd a polyclonal antiserum against CypA (C). The wild-type plasmid pNL4
ndicates a different proviral clone from which the P90L mutant was derived
n lanes 1–10 was normalized according to the HIV-1 CA antigen content. L
ane. (D) HIV-1 and HIV-2 particles obtained from infected MT-4 cells grown
y Western blotting using a mixture of antisera against HIV-1 and HIV-2 CA
IV-specific precursor protein and cleavage products are defined on theppeared slightly less efficient in the case of the HXBH10 wirus, and the derived mutant and residual polyprotein
nd cleavage intermediates were observed (Fig. 1B,
anes 9 and 10).
Western blot analysis of particle fractions using a
ixture of antisera against CypA and CA was performed
o analyze their relative CypA incorporation. To allow for
semiquantitative estimation, all samples were normal-
zed for CA content, and serial 2-fold dilutions of wild-
ype virus grown in the absence of cyclosporin were
oaded in parallel (Fig. 1C, lanes 11–14). CypA incorpo-
ation was drastically reduced in all mutant viruses and
n the case of wild-type virus grown in the presence of
yclosporin (Fig. 1C). Cyclosporin treatment, as well as
utations G89A, G89V, and G89W, reduced CypA incor-
oration 5- to 10-fold (Fig. 1C, compare lanes 2 and 6–8
ls were transfected with pNL4-3 or derivatives, and media were harvested
ted by centrifugation through a sucrose cushion (B and C) were analyzed
lonal antiserum against HIV-1 CA (A and B) or a mixture of this antiserum
) and mutant proviral constructs are indicated above each lane. HXBH10
dition of 5 mM CSA is indicated at the top as well. (C) The material loaded
1–14 correspond to serially diluted WT samples as indicated above each
bsence or presence of CSA (as indicated above each lane) were analyzed
ainst CypA. Molecular mass standards (in kDa) are indicated on the left.R5 cel
s collec
a polyc
-3 (WT
. The ad
anes 1
in the a
and agith lane 13; Table 1). Slightly higher relative CypA in-
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264 WIEGERS ET AL.orporations were observed for mutants G89L and G89C
Fig. 1C, lanes 3 and 4; Table 1), whereas mutant G89F
educed CypA incorporation to only 30% of wild-type
irus (Fig. 1C, lane 5; Table 1). The largest effect was
bserved for mutant P90L, which caused a decrease in
ypA content to ;5% of wild-type virus (Fig. 1C, lane 9;
able 1). This residual amount of CypA may correspond
o background levels due to cellular debris and vesicles
ather than to specific incorporation. As a negative con-
rol, we analyzed HIV-2 virions in parallel, which have
een shown to be unaffected by cyclosporin and to lack
ypA (Billich et al., 1995; Franke et al., 1994; Thali et al.,
994). HIV-1 and HIV-2 were grown in MT-4 cells in the
bsence or presence of 5 mM cyclosporin. Virus particles
ere harvested as described above, normalized for CA
ntigen, and analyzed by immunoblotting using a mixture
f antisera against HIV-1 and HIV-2 CA and against
ypA. Cyclosporin treatment induced a similar decrease
n CypA incorporation into HIV-1 particles produced from
nfected cultures as observed before for transfected cells
Figs. 1D, lanes 1 and 2, and 1C, lane 1 and 2). Low
mounts of CypA comparable to those observed in drug-
reated HIV-1 were detected in HIV-2 preparations grown
n the absence of cyclosporin (Fig. 1D, lanes 2 and 3).
ypA content was further reduced by cyclosporin treat-
ent of HIV-2-infected cells.
It has been shown that cyclosporin treatment or mu-
ations in the CypA-binding loop reduce infectivity of
TABLE 1
Infectivity and Cyclophilin A Content of Wild-Type and Variant HIV-1
Virus
Infectivity in
Cyclophilin A
content (%)C8166 cells HeLa P4/CCR5 cells
T 4.0 3 106 4.0 3 105 100
T 1 CSA 6.0 3 104 5.8 3 103 15
89A 3.3 3 104 4.2 3 103 15
89V 8.3 3 104 2.8 3 103 15
89L 1.8 3 104 1.8 3 103 20
89F 1.3 3 103 1.3 3 103 30
89W 8.3 3 103 4.4 3 102 15
89C 4.0 3 102 ,5 3 101 20
90L 3.3 3 103 ,5 3 101 5
XBH10 (WT) 9.7 3 104 1.9 3 103 100
Note. Virus particles were generated by transfection of HeLa P4/
CR5 cells with the respective proviral plasmids. WT 1 CSA denotes
irus production in the presence of 5 mM cyclosporin. The P90L variant
as constructed in the molecular clone HXBH10 and therefore is
ompared with the corresponding wild-type virus. Cyclophilin content
f virus particles was estimated from the data shown in Fig. 1 and is
hown relative to WT HIV-1 (100%). Infectivity in C8166 cells was scored
y syncytium formation; infectivity in HeLa P4/CCR5 cells was deter-
ined by X-gal staining. Titers were normalized according to the CA
ntigen content and are given as TCID50 /ml. Virus titers were deter-
ined for three separate transfections (two in case of WT 1 CSA and
89A) and results from a representative experiment are shown.IV-1 (Billich et al., 1995; Franke et al., 1994; Thali et al., o994), but a comparative analysis of different viruses
elating their respective infectivities and CypA incorpo-
ation levels has not been reported. We therefore deter-
ined the infectivity of wild-type virus grown in the pres-
nce or absence of cyclosporin and of the various mu-
ant viruses by using the T cell line C8166 and HeLa
4/CCR5 indicator cells. Titers were generally lower in
eLa P4/CCR5 cells, but no major differences were ob-
erved in the relative titers. Table 1 shows the infectious
iters of the different viruses normalized for their respec-
ive CA content and the CypA incorporation as deter-
ined in the experiment shown in Fig. 1. Cyclosporin
reatment reduced the infectious titer of HIV-1 (NL4-3) by
factor of 50–100. A similar titer reduction was observed
or mutants G89A and G89V compared with wild-type
L4-3 and for mutant P90L compared with wild-type
XBH10 (Table 1). Mutants G89L and G89F showed a
urther decrease in infectious titer, although these vi-
uses contained a higher amount of CypA (Table 1).
ignificantly lower titers than for the other mutants were
bserved for mutant G89W and in particular for mutant
89C (Table 1). In addition, these mutants exhibited
ignificantly more variability in infectious titers (data not
hown).
lectron microscopic analysis of wild-type and mutant
irions containing variable amounts of CypA
To analyze the morphology of immature and mature
irus particles, thin-section electron microscopic analy-
is of HeLa P4/CCR5 cells transfected with wild-type
NL4-3 and grown in the absence or presence of cyclo-
porin or transfected with the various CypA-binding mu-
ants was performed. No distinct morphological pheno-
ype could be detected for cyclosporin-treated virus.
IV-1 particles produced in its presence exhibited the
ize and morphology of untreated virus and contained
egular cone-shaped capsids (Fig. 2). The number of
isintegrated particles appeared to be slightly increased
fter cyclosporin treatment. Regular mature virions of
ormal size containing cone-shaped electron dense cap-
ids were also readily observed for mutants G89A, G89L,
90L (Fig. 2), G89C (data not shown), and G89V (Fig. 6).
or mutants G89C and P90L, a slightly altered irregular
apsid morphology was sometimes observed. Signifi-
antly fewer virions were observed in the case of mutant
89L, although many budding structures were detected.
his result indicates that G89L virions may disintegrate
ore rapidly. Immature virions of normal size and mor-
hology were detected in all cases, but a slight increase
n the number of immature particles was evident for
utants G89L and P90L (Fig. 2).
Significant morphological alterations were observed
or mutants G89W and G89F. Many extracellular virions
ontaining condensed electron-dense structures were
bserved for G89W. However, viral cores showed an
W
v
a
265CYCLOPHILIN A INCORPORATION AND HIV TYPE 1FIG. 2. Electron micrographs showing thin sections of HeLa P4/CCR5 cells transfected with pNL4-3 (WT) and derivatives at 64 h after transfection.
T virus was grown in the presence of 5 mM CSA (WT 1 CSA). The various mutations are identified in each panel. In the case of G89L and P90L
irions, two pictures are shown depicting immature and budding particles and mature virions, respectively. In the case of G89F virions, four pictures
re shown because particles were much more rarely detected than in the other cases.
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266 WIEGERS ET AL.berrant morphology with irregular condensation and
ncreased staining (Fig. 2). Considerably fewer particles
ere observed for mutant G89F, and these particles
enerally exhibited heavily stained cores of irregular
orphology and lacked condensed capsid structures
Fig. 2). Rare G89F particles showed a condensed capsid
omparable to that of wild-type HIV-1 (Fig. 2, lower right).
udding structures of normal size and morphology and
egular immature virions were observed in both cases,
ndicating that the defects mostly affected capsid con-
ensation during virion maturation.
educed CypA incorporation does not affect Gag
rocessing and virion maturation
In a recent report, it was suggested that CypA incor-
oration reduces HIV-1 Gag polyprotein processing and
irion maturation (Streblow et al., 1998). The experiments
hown above indicated that no gross defect occurred in
his regard when extracellular particles harvested late
fter transfection were analyzed. However, a more subtle
ffect of CypA on polyprotein processing may be re-
ealed only if the time course of Gag turnover is ana-
yzed. We therefore performed pulse-chase experiments
n an infected T cell line grown in the presence or
bsence of cyclosporin and on HeLa cells transfected
ith wild-type proviral plasmids or CypA-binding mu-
ants. A3.01 cells infected with HIV-1 (NL4-3) were split
nto parallel cultures near peak virus replication, and one
ulture was treated with 7.5 mM cyclosporin. After 3 h of
ncubation, a pulse-chase experiment was conducted.
ells were pulse-labeled for 30 min with [35S]methionine
nd chased in the absence of isotopically labeled amino
cids for up to 4 h in the presence or absence of cyclo-
porin. Detergent lysates of cells, the viral pellet, or the
larified supernatant fractions were subjected to immu-
oprecipitation with HIV-1-specific antisera and analyzed
y SDS–PAGE and fluorography (Figs. 3A and 3B). To
stimate the efficiency of Gag polyprotein processing
nd virus particle release, radioactive bands correspond-
ng to Pr55gag and the cleavage product CA were quan-
ified using an Image Analyzer and the percentages of
irus particle-associated Gag proteins released into the
upernatants were calculated and plotted as a function
f time (Fig. 3C). To quantify the efficacy of Gag process-
ng detected in cell lysates, the conversion of Pr55gag into
ts major processing product CA was analyzed for each
f the chase time points, and the ratio of CA versus
r55gag was plotted against time (Fig. 3D). Results from
his experiment indicated that particle release and
olyprotein processing were not reduced by cyclosporin
reatment. In contrast, virus release occurred slightly
aster in the presence of cyclosporin, and the rate of
ntracellular Gag polyprotein processing was slightly in-
reased by the drug. The same phenotype was observedor HeLa cells transfected with pNL4-3 and cultivated in che presence or absence of cyclosporin (data not
hown).
To study the time course of Gag processing and par-
icle release for variants defective in CypA binding, sim-
lar pulse-chase experiments were conducted in HeLa
ells transfected either with wild-type pNL4-3 or mutants
89L and G89V (Fig. 4) or with pHXBH10 and mutant
90L (data not shown). Figure 4C shows that virus re-
ease was slightly faster for mutants G89V and G89L
ompared with wild type, similar to what had been ob-
erved for cyclosporin treatment of infected T cell cul-
ures (Fig. 3). Furthermore, intracellular Gag polyprotein
rocessing occurred more rapidly in the case of mutant
89V compared with wild type and even more so for
utant G89L (Fig. 4D). The same phenotype was also
bserved when virus release and Gag processing were
nalyzed for mutant P90L and the corresponding wild-
ype provirus pHXBH10 in transfected HeLa cells (data
ot shown).
A subtle effect of cyclosporin on virion maturation may
e detectable only on short-term incubation, and it has
een reported recently that the treatment of HIV-1-in-
ected T cells with cyclosporin for 3 h causes a signifi-
ant increase in the relative number of particles with
mmature morphology (Streblow et al., 1998). This obser-
ation is in contrast to the results from the described
ulse-chase analysis; we therefore analyzed the effect of
hort-term cyclosporin treatment on virion maturation by
lectron microscopy. Parallel cultures of HeLa cells were
ransfected with pNL4-3 or mutant G89V, and cyclosporin
5 mM) was added to one culture after 64 h. Medium was
eplaced 1 h later, and virus particles were harvested
fter cultivation for additional 3 h in the presence or
bsence of the drug. CypA incorporation was analyzed
y immunoblotting using antisera against CA and CypA.
igure 5 shows that cyclosporin treatment effectively
educed the CypA content of particles released within
he 3-h time period. Virtually no CypA was detectable in
89V particles produced in the presence or absence of
yclosporin (Fig. 5). Thin-section electron microscopic
nalysis of transfected cells revealed mature virions with
ypical cone-shaped capsids in all cases (Fig. 6). No
ncrease in the number of immature particles was de-
ected for wild-type virus cultivated in the presence of
yclosporin and harvested over a 3-h time period (Fig.
c). Similarly, abundant mature virions and only few im-
ature particles were observed for G89V-transfected
ells cultivated in the absence or presence of drug for a
-h period (Figs. 6a and 6b).
educed CypA incorporation does not increase
apsid stability after detergent stripping of virions
Detergent treatment of mature HIV-1 particles readily
olubilizes the viral capsid releasing a ribonucleoprotein
omplex consisting of the genomic RNA and associated
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267CYCLOPHILIN A INCORPORATION AND HIV TYPE 1roteins (Emerman, 1996; Gallay et al., 1995; Liu et al.,
995; Rose et al., 1995). Previous studies suggested that
apsid stability may be affected by CypA binding to the
iral CA protein, which may weaken protein interactions
Gamble et al., 1996). To detect subtle changes in capsid
tability, we collected wild-type HIV-1 and HIV-2 particles
roduced in the presence or absence of cyclosporin and
articles from various CypA-binding mutants. Subse-
uently, virions were centrifuged through a layer of su-
rose either containing or lacking 0.5% Triton X-100. This
reatment results in a brief contact time of particles with
etergent, and electron microscopic analysis of the pel-
et obtained from wild-type HIV-1 virions revealed the
resence of cone-shaped capsids lacking the virion
embrane (R. Welker and H.-G.K., unpublished observa-
ion). Sedimented material was analyzed by Western blot
FIG. 3. Effect of cyclosporin on the time course of virus particle
ulse-chase experiments were conducted in cultures of A3.01 cells infe
.5 mM cyclosporin. Viral proteins recovered from the cell lysates, pellet
nalyzed by fluorography. Parts of the fluorograms demonstrating Pr55
and B. HIV Gag proteins and molecular mass standards are indicate
f cyclosporin was calculated as the percentage of Gag proteins (Pr55
ntracellularly and extracellularly (C). (D) Time course of intracellular Pr
r55 detected in the cell lysates.sing antisera against CA and MA. In addition, quantita- give ELISA for HIV-1 CA was performed, and the relative
mount of CA protein in the pellet fractions from gradi-
nts containing or lacking detergent (in percentages)
as taken as a measure of capsid stability. The mem-
rane-associated MA protein, which is not part of the
nner capsid structure, was completely solubilized under
hese conditions (Figs. 7A and 7B, compare even and
dd lanes). Approximately 30% of CA protein remained
s a stable complex after centrifugation of wild-type
IV-1 through the detergent layer (Fig. 7A, lanes 1 and 2).
tripped capsids from HIV-1 particles produced in the
resence of cyclosporin exhibited a slightly reduced sta-
ility with 20% of CA antigen sedimenting through the
etergent layer (Fig. 7A, lanes 3 and 4). Similarly, no
ncrease in capsid stability was observed for any of the
utants analyzed, with relative CA contents in the deter-
and Gag polyprotein processing in HIV-1-infected T cell cultures.
th HIV-1 (NL4-3) near peak virus replication and treated with or without
ns, and clarified supernatant (not shown) by immunoprecipitation were
A precipitated from the cell lysates and pelleted virions are shown in
retion of virus particles produced in the presence (f) or absence (F)
) present in the virus pellet relative to the total Gag proteins detected
processing was estimated by calculating the ratio of CA protein overrelease
cted wi
ed virio
and C
d. Sec
and CA
55 Gagent-stripped sediments ranging from 10% to 24% (Fig.
7
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268 WIEGERS ET AL.A, lanes 5–14). We also analyzed the stability of stripped
IV-1 and HIV-2 capsids produced from infected T cells
rown in the presence or absence of cyclosporin (Fig.
B). Again, no significant effect of cyclosporin treatment
as observed (Fig. 7B, lanes 1–4). HIV-2 capsids exhib-
ted a slightly greater stability than HIV-1 capsids after
etergent treatment (Fig. 7B, lanes 4–8).
DISCUSSION
Retrovirus assembly, maturation, and disassembly are
omplex processes. First, a stable structure, consisting
redominantly of Gag polyproteins, is assembled in the
irus-producing cell. During extracellular maturation, this
ust be converted into a metastable capsid. This pro-
ess involves major rearrangements of the structural
omponents, which are present in millimolar concentra-
ions inside the virion. It appears likely, therefore, that
FIG. 4. Analysis of particle release and Gag polyprotein processing fo
ith 75 mg of plasmid DNA of the molecular clone pNL4-3 or derivative
o that described in Fig. 3 except that the chase time was extended for u
he cell lysates, and pelleted virions are shown for NL4-3 (A) and for th
rocessing (D) were calculated according to the procedure describedight temporal and spatial control of events during mat- iration is required for formation of an infectious struc-
ure. Finally, on removal of the virion lipid envelope by
usion with the host cell membrane, the capsid is disas-
embled to release the viral genome and replication
roteins. Most currently available data indicate that
ypA in the case of HIV-1 exerts its influence on one or
everal of these steps. It is generally assumed that the
revention of CypA incorporation leads to defects after
irus entry, most likely before reverse transcription
Braaten et al., 1996; Steinkasserer et al., 1995; Thali et
l., 1994). It should be noted, however, that defects in any
tep subsequent to particle release will be manifested at
he time of virus entry and, unless there are obvious
orphological alterations, may be detected only in entry
ssays.
Previous studies using pharmacological agents and
enetic changes have shown that CypA incorporation is
philin-binding mutants. Parallel cultures of HeLa cells were transfected
h posttransfection, a pulse-chase experiment was conducted similar
h. Parts of the fluorograms demonstrating Pr55 and CA recovered from
mutant (B). Kinetics of virus particle release (C) and intracellular Gag
legend to Fig. 3. F, WT virus. f, Mutant G89V. l, Mutant G89L.r cyclo
s. At 24
p to 8
e G89Vmportant for HIV-1 infectivity (Braaten et al., 1996; Buk-
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269CYCLOPHILIN A INCORPORATION AND HIV TYPE 1vsky et al., 1997; Franke et al., 1994; Steinkasserer et al.,
995; Thali et al., 1994). The phenotype observed was
urther dependent on the CypA content of the virus-
roducing cell (Ackerson et al., 1998; Yin et al., 1998),
ndicating a narrow constraint on CypA stoichiometry in
irions. However, the precise function of CypA in HIV-1
eplication has not been determined to date. In this
tudy, we analyzed the effect of decreased CypA pack-
ging on virion morphology, maturation, and capsid sta-
ility. Consistent with previous results (Braaten et al.,
996), we report that the presence or absence of CypA
oes not detectably alter the yield or morphology of
FIG. 5. Immunoblot analysis of viral particles after transfection and
hort-term cultivation in the presence of CSA. At 64 h after transfection,
ild-type (WT) and G89V mutant transfected HeLa P4/CCR5 cells were
ultured for 4 h in the absence or presence of 5 mM CSA. Viral particles
eleased during this time were collected and analyzed as described in
he legend to Fig. 1. Immunodetection was performed using a mixture
f polyclonal sera against CA and CypA. Positions of CA, CypA, and
olecular-mass standards are indicated.
FIG. 6. Electron micrographs showing thin sections of HeLa P4/CC
ransfection. The culture medium had been removed 4 h before fixation and repature extracellular particles, but viral infectivity is de-
reased by a factor of 10 to 100 if CypA is absent. Certain
mino acid changes in the CypA-binding loop (e.g.,
89L, G89W) caused significantly aberrant capsid mor-
hologies, but these effects did not correlate with the
elative CypA packaging of the respective virions. It is
ore likely that they reflect alterations in the interaction
omains of the respective CA proteins. Changes in the
orphology of the mature capsid without effects on virus
udding or morphology of the immature virion have pre-
iously been reported for several other variants in the
mino-terminal domain of CA (Dorfman et al., 1994; Re-
cin et al., 1995; Wang and Barklis, 1993).
Consistent with previous reports, we also showed that
o gross defect in virion maturation can be detected if
irus particles lacking CypA are analyzed late after trans-
ection or infection. This result does not exclude an effect
f CypA on the kinetics of this process, thus influencing
irus infectivity. Recently, it has been reported that CypA
ight indeed delay processing and maturation (Streblow
t al., 1998). Both the pulse-chase experiments and the
hort-term harvest electron microscopic analysis con-
ucted in our study disagree with this hypothesis. In
ontrast, our data indicate that intracellular Gag process-
ng, as well as particle release, occurs slightly faster in
he absence of CypA. Whether this subtle effect is rele-
ant for the mechanism of CypA action is currently not
lear. No increase in the relative number of immature
irions was observed on short-term harvest of virus pro-
uced from cyclosporin-treated cells or of variants de-
ective in CypA incorporation.
Based on structural analyses, it had been suggested
hat CypA may destabilize the mature viral capsid, effec-
ively acting as an uncoating factor (Gamble et al., 1996).
n this case, it would be expected that virions lacking
ypA should contain more stable capsid structures that
s transfected with pNL4-3 (c) or mutant G89V (a and b) at 68 h afterR5 cell
laced with fresh medium lacking (a) or containing (b and c) 5 mM CSA.
f
d
c
i
H
T
t
d
b
d
a
u
a
a
t
n
d
p
v
i
m
T
t
t
v
t
p
t
o
o
a
a
(
i
q
l
(
d
b
U
s
v
C
c
s
T
C
b
t
a
f
p
p
1
C
l
t
m
V
c
S
A
m
T
i
m dentifie
270 WIEGERS ET AL.ail to be removed on membrane fusion, leading to a
efect in virus entry. Our data indicate, however, that the
apsid stability of detergent-treated virions lacking CypA
s not significantly increased compared with wild-type
IV-1. Instead, we observed a minor decrease in stability.
hese experiments were performed by centrifuging in-
act virus through a layer of detergent to be minimally
isruptive. However, the events occurring during mem-
rane fusion probably are not precisely reproduced by
etergent treatment, and these experiments alone do not
llow us to conclude that CypA does not play a role in the
ncoating process. Additional arguments against CypA
s a destabilizing agent can be drawn from the in vitro
ssembly experiments in the accompanying paper (Gra¨t-
inger et al., 1999). These studies showed that CypA does
ot have a negative effect on in vitro assembly of CA-
erived cylinders and cannot disintegrate preassembled
articles when present at a molar ratio, as found in the
irion (10:1; CA/CypA). Decay of in vitro assembled cyl-
nders was observed only when CypA was present in a
olar excess over CA for extended periods of time.
aken together, these data argue that CypA is not likely
o function by actively disintegrating the viral capsid in
he entry process.
If, as our data suggest, CypA does promotes neither
irus production nor maturation or disassembly, what
arget does it have, and what other possible role could it
lay in HIV-1 replication? All available evidence indicates
hat CypA acts directly on HIV-1 CA and more specifically
FIG. 7. Analysis of detergent stability of wild-type (WT) HIV particles g
iral particles were collected from the medium of transfected HeLa P4/C
ontaining a layer of 10% sucrose with or without 0.5% Triton X-100 on
DS-PAGE and Western blot analysis using a polyclonal antiserum aga
fter stripping, the blot was reprobed with a polyclonal antiserum aga
inescence. For the preparation of the figure, both exposures wer
ransfection with the wild-type proviral construct and the respective mut
n the presence of 5 mM CSA is also described. The presence or absen
ass standards are shown on the left, and HIV-specific proteins are in an eight-amino-acid stretch in the CypA-binding loop df CA. It interacts with the CA domain of Gag (Franke et
l., 1994; Thali et al., 1994) and with mature CA (Luban et
l., 1993), and it binds to in vitro assembled CA particles
Gra¨ttinger et al., 1999). Mutational analyses and exper-
ments using chimeric virions have shown that the re-
uirement for CypA segregates with the CypA-binding
oop of HIV-1. Not only the primary binding site for CypA
residues 88–90 of CA), but also a type II tight turn
irectly adjacent to it (residues 92–95 of CA), appears to
e important for CypA function (Bukovsky et al., 1997).
sing in vitro assembly of purified proteins, we have
hown that CypA at the same molar ratio to CA as in the
irion exerts a positive influence on particle formation.
ylinders assembled at these conditions grew signifi-
antly longer and were less aggregated than those ob-
erved in the absence of CypA (Gra¨ttinger et al., 1999).
hese observations could be explained by assuming that
ypA, at least transiently, interacts with capsid building
locks (i.e., CA monomers or oligomers) and prevents
hem from undergoing off-pathway reactions like random
ggregation. Previous reports had suggested similar
unctions for cyclophilins on other proteins, also sup-
ressing off-pathway folding reactions and preventing
rotein aggregation (Freeman et al., 1996; Lilie et al.,
993). Based on these results, one can hypothesize that
ypA interacts in an analogous way with CA molecules
iberated during Gag processing inside the virion,
hereby improving the coordination of capsid rearrange-
ent and increasing virus infectivity. A lack of CypA
n the presence or absence of cyclosporin and of mutant HIV particles.
lls (A) or infected MT-4 cells (B) and layered on a sucrose step gradient
20% sucrose layer as described in the text. Pellets were resolved by
V-1 CA (A) or a mixture of antisera against HIV-1 CA and HIV-2 CA (B).
IV-1 MA. Secondary antibodies were detected by enhanced chemilu-
rimposed according to the position of molecular mass standards.
infection with HIV-1 or HIV-2 are indicated above each lane. Cultivation
.5% Triton X-100 in the step gradient is indicated by 1 or 2. Molecular
d between the two panels.rown i
CR5 ce
top of a
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ce of 0uring virus maturation would then lead to an increase in
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271CYCLOPHILIN A INCORPORATION AND HIV TYPE 1nproductive interactions between CA molecules. This
oes not necessarily result in morphological changes
isible at the resolution of thin-section electron micros-
opy but may lead to phenotypical defects at the time of
irus entry.
It is important to note that HIV-2 and SIV do not incor-
orate CypA and do not need it for their replication,
lthough the replication pathways of the closely related
entiviruses are likely to be largely similar. One would
ssume, therefore, that the effect of CypA on HIV-1 in-
ectivity can also be achieved by other means, most
ikely affecting the CA domain. Accordingly, CypA-inde-
endent variants of HIV-1 can be readily selected on
ultivation in the presence of cyclosporin, and even virus
ariants that are blocked by CypA and require the pres-
nce of cyclosporin for their growth have been observed
Aberham et al., 1996; Yin et al., 1998). On the other hand,
ypA incorporation and sensitivity toward cyclosporin
re highly conserved among HIV-1 isolates, indicating a
elective advantage. Possibly, the requirements on the
A interaction domains are less stringent in the pres-
nce of the chaperone CypA, thus allowing for higher
equence variability and higher versatility of the system.
o achieve this advantage, CypA incorporation must be
inely tuned. Either enhancement of or reduction in in-
ectivity were observed on cyclosporin treatment, de-
ending on the CypA content of the producer cell, the
ypA-binding affinity of the CA domain of the respective
irus, and the sequence of the type II turn (Bukovsky et
l., 1997; Yin et al., 1998). Specific combinations of these
actors may lead to significant disorder of the capsid
one when there is too much CypA for a given CA
equence, whereas off-pathway reactions prevail when
here is too little CypA.
MATERIALS AND METHODS
ells, transfections, and infections
HeLa P4 cells (Clavel and Charneau, 1994) stably
xpressing the CCR5 coreceptor (HeLa P4/CCR5) were
indly provided by M. Alizon (Institut Cochin de Genet-
que Moleculaire, Paris, France) and maintained in Dul-
ecco’s modified minimal Eagle’s medium supplemented
ith 10% heat-inactivated FCS, 100 U/ml penicillin, 100
g/ml streptomycin, and 2 mM glutamine. For transfec-
ions, cells were seeded onto 10-cm culture dishes and
ransfected with 15 mg of plasmid DNA using a modified
alcium phosphate method (Chen and Okayama, 1987).
fter overnight incubation at 35°C and 3% CO2, the cells
ere washed twice with PBS, and the medium was
eplaced. CSA (Sandimmun, Sandoz AG, Nu¨rnberg, Ger-
any) was diluted to a 4.2 mM stock solution in PBS.
ells and medium were harvested 64 h after transfec-
ion. For short-term drug treatment, 5 mM CSA was
dded 64 h after transfection; 1 h later, medium waseplaced with fresh medium containing 5 mM CSA, and mhe cells were incubated for an additional 3 h in the
resence of the drug. Control transfections without drug
ddition were subjected to the same treatment.
HIV-1 permissive MT-4 cells (Harada et al., 1985),
8166 cells (Salahuddin et al., 1983), and A3.01 cells, a
erivative of the CEM human T lymphocytic cell line,
hich was selected for high-level expression of CD4
Folks et al., 1985), were maintained in RPMI 1640 with
he supplements described above. Infection of MT-4
ells was initiated from cell-free supernatants of HIV-1
strain NL4-3; Adachi et al., 1986) or HIV-2 (strain CBL20;
chulz et al., 1990) stocks. Cultures containing 90% in-
ected cells as determined by indirect immunofluores-
ence were diluted 6-fold with fresh uninfected MT-4 or
3.01 cells. Cells were washed after 6 h, and the medium
as replaced by fresh medium with or without CSA (5 or
.5 mM final concentration). Virus was harvested 24 h
ater by centrifuging cells at 400g and filtering the super-
atant through a 0.45-mm filter.
For virus titration, C8166 cells were seeded onto mi-
rotiter plates at a concentration of 2 3 105 cells/ml, and
ultures were infected in quadruplicate with 100 ml of
iltered virus serially diluted in complete medium. Infec-
ivity was scored as tissue culture infectious dose 50%
TCID50) by counting syncytia formation after cultivation
or 1 week. For single-cycle infectivity assays, HeLa
4/CCR5 cells were plated onto 24-well plates and in-
ected in duplicate 1 day later with 0.25 ml of serially
iluted virus. Complete medium was added after 2 h.
ells were cultured for 3 days and were fixed and
tained with 5-bromo-4-chloro-3-indolyl-galactopyrano-
ide (X-gal) as described previously (Kimpton and Emer-
an, 1992). Blue cells were counted under the micro-
cope, and the mean values calculated and multiplied by
he virus dilution. The infectivity of a given virus was
ormalized for the CA antigen content of the virus inoc-
lum as determined by quantitative ELISA.
lasmid constructions
Construction of prokaryotic expression vectors con-
aining mutations of the Gly89 codon in the CA coding
omain is described in the accompanying paper (Gra¨t-
inger et al., 1999). Prokaryotic expression vectors har-
oring the mutants G89A and G89V were a kind gift of W.
undquist (University of Utah) and have been described
reviously (Yoo et al., 1997). All plasmids were cleaved
ith SphI (nucleotide 1448 of the pNL4-3 sequence) and
peI (nucleotide 1508), and the resulting 60-bp fragments
ere ligated into pNL4-3 that had been cleaved with the
ame enzymes. The proviral plasmid pHXBH10 (Ratner et
l., 1987) and a derivative containing a P90L mutation in
he CA domain were kindly provided by R. Wagner (Uni-
ersity of Regensburg). The presence of the respective
utations was verified by DNA sequence analysis.
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272 WIEGERS ET AL.urification and detergent treatment of virus particles
Extracellular particles were collected from cleared me-
ia (10 min at 400g followed by filtration through a
.45-mm pore size filter) by centrifugation through a 2-ml
ushion of 20% (w/w) sucrose in PBS at 130,000g for 90
in at 4°C. Pellets were resuspended in SDS loading
uffer and analyzed by gel electrophoresis and Western
lotting. For detergent treatment of virus particles,
leared culture medium from transfected cells was cen-
rifuged through preformed step gradients containing a
ushion of 20% (w/w) sucrose in PBS and a 1-ml layer of
0% sucrose in PBS with or without 0.5% Triton X-100 as
escribed previously (Wiegers et al., 1998). Centrifuga-
ion was performed at 130,000g for 120 min at 4°C. The
ellets were resuspended in SDS loading buffer and
nalyzed by PAGE followed by Western blot as well as by
LISA.
nalysis of expression products
HIV antigens were analyzed using a quantitative
LISA detecting the viral CA protein (Konvalinka et al.,
995). For protein analysis, cell or particle extracts were
eparated on 12.5% SDS–polyacrylamide gels. For immu-
oblot analysis, proteins were transferred to nitrocellu-
ose membranes (Schleicher & Schuell) by electroblot-
ing. Membranes were blocked with 10% low-fat dry milk
n PBS for 1 h and subsequently reacted with rabbit
olyclonal antiserum against HIV-1 CA, HIV-2 CA, or
ypA. The antisera were diluted 1:4000 (HIV-1 CA, HIV-2
A) or 1:1000 (CypA) in PBS containing 10% newborn calf
erum. Incubation was carried out overnight at room
emperature with shaking. After washing three times with
BS containing 0.05% Tween 20 and blocking for 30 min
ith PBS containing 5% low-fat dry milk, peroxidase-
onjugated anti-rabbit serum (Jackson Immunochemi-
als Inc.; dilution 1:5000) was used as secondary anti-
ody and incubated for 2 h at room temperature. Immune
omplexes were visualized using enhanced chemilumi-
escence (ECL; Amersham) according to the manufac-
urer’s instructions.
etabolic labeling, pulse-chase, and
mmunoprecipitation
Transfected HeLa cells or infected A3.01 cells were
ashed once with PBS and starved for 60 min in methi-
nine-free RPMI 1640 medium (Specialty Media, Inc.,
avalette, NJ). Cells were pulse-labeled with [35S]methi-
nine (2 mCi/ml, Amersham Life Science Inc., Arlington
eights, IL) for various times. The medium was then
emoved, the cells were washed once in PBS, and equal
mounts were added to prewarmed medium for each
ime point of the chase period and incubated at 37°C
hile being shaked gently. At the indicated time points,ells were collected and stored on dry ice. For studying wirus particle release, the supernatants were centrifuged
2 min, 16,000g), and cell-free virus particles were pel-
eted (4°C, 100 min, 16,000g) and lysed in a buffer con-
aining 300 mM NaCl, 50 mM Tris–HCl, pH 7.4, and 0.1%
v/v) Triton X-100. Cells were lysed in a buffer containing
0 mM Tris–HCl, pH 8.0, 5 mM EDTA, 100 mM NaCl, 0.5%
w/v) [3-[(3-cholamidopropyl)-dimethyl-ammonio]-1-
ropanesulfonate], and 0.2% (w/v) deoxycholate. Cell ly-
ates were precleared by incubation at 4°C for 1 h with
ammaBind-G-Sepharose beads (Pharmacia LKB Bio-
echnology, Piscataway, NJ) preadsorbed with IgG from
abbit, human, mouse, and sheep sera. Immunoprecipi-
ations were conducted as described previously (Schu-
ert and Strebel, 1994) using antibodies preadsorbed to
ammaBind-G-Sepharose beads. Immunoprecipitated
roteins were solubilized by boiling in sample buffer and
eparated on 12.5% Acryl aide gels (FMC Bioproducts,
ockland, ME). Gels were fixed for 30 min by incubation
n 40% methanol and 10% acetic acid, rinsed with water,
oaked in 1 M sodium salicylate for 2 h, and dried.
uantification of fluorograms was performed by expos-
ng gels to PhosphorImager screens (Molecular Dynam-
cs, Sunnyvale, CA), which were imaged and quantified
y using the PhosphorImager software.
ntisera
Polyclonal rabbit antiserum against HIV-1 CA has been
escribed previously (Mergener et al., 1992). Antiserum
gainst HIV-2 CA was made against purified bacterially
xpressed protein and antiserum against CypA was a
ift of U. v. Schwedler (University of Utah). g-Globulin
repared from pooled plasma of healthy HIV-1-positive
onors (NIH AIDS Research and Reference Reagent Pro-
ram, catalog no. 192) was used to detect HIV-1-specific
roteins by immunoprecipitation. In addition, a poly-
lonal anti-Vpu antiserum (rabbit), directed against a syn-
hetic peptide consisting of residues 32–81 of Vpu (Schu-
ert et al., 1998), was used.
lectron microscopy
At 64 h after transfection, cells were fixed in situ for 20
in with cold 2.5% glutaraldehyde in 100 mM piperazine-
,N9-bis(2-ethanesulfonic acid) (PIPES), pH 6.9. Fixed
ells were scraped from the plate with a rubber police-
an and collected by low-speed centrifugation at 4°C,
ashed three times in cold PIPES, and postfixed in 1%
smium tetroxide in PIPES for 30 min at 4°C. After ex-
ensive washing in PIPES, cells were embedded in aga-
ose (low gelling temperature; Sigma) and further treated
ith 1% tannic acid for 10 min. Finally, agar blocks were
ashed in water, stained with 1% uranyl acetate for 30
in in the cold, dehydrated in ethanol, and embedded in
RL resin (Spurr, 1969). Silver-gray sections were stained
ith lead citrate and uranyl acetate. Sections were ex-
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273CYCLOPHILIN A INCORPORATION AND HIV TYPE 1mined under a Philips CM120 electron microscope at
0 kV.
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